Skip to main content
. 2022 Mar 7;13:806787. doi: 10.3389/fphar.2022.806787

TABLE 5.

Cost minimization analysis in phase Ⅲ

No Medication combination Hospitalization records (N) Total hospitalization costs (mean), CNY p value
The whole group
1 PPC 1,528 31,488.6 0.125
Magnesium isoglycyrrhizinate 2,299 33,933.8
2 PPC + glutathione 1,509 40,797.1 0.000
Glutathione 2,222 34,985.2
3 PPC + magnesium isoglycyrrhizinate 969 35,962.3 0.000
Magnesium isoglycyrrhizinate + glutathione 2,160 42,547.3
4 PPC + magnesium isoglycyrrhizinate + glutathione 1,088 44,362.7 0.964
Magnesium isoglycyrrhizinate + glutathione 2,658 44,864.0
Postoperation of nontumor/liver transplantation group
 1 PPC 766 33,965.5 0.172
Magnesium isoglycyrrhizinate 1,208 37,730.1
 2 PPC + glutathione 622 43,073.6 0.215
Magnesium isoglycyrrhizinate + glutathione 1,181 47,122.2
Abnormal liver function group
 1 PPC 398 40,018.9 0.708
Glutathione 543 47,284.4
 2 PPC 409 35,925.6 0.101
Magnesium isoglycyrrhizinate 409 42,245.6
 3 PPC + glutathione 344 49,194.6 0.000
Glutathione 546 42,243.8

Abbreviations: PPC, polyene phosphatidyl choline; CNY, China yuan.